Capital Analysts LLC’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-130
Closed -$2K 1607
2026
Q1
$2K Buy
+130
New +$1.62K ﹤0.01% 1475
2022
Q3
Sell
-29
Closed -$1K 1133
2022
Q2
$1K Hold
29
﹤0.01% 1004
2022
Q1
$1K Hold
29
﹤0.01% 922
2021
Q4
$2K Hold
29
﹤0.01% 964
2021
Q3
$2K Hold
29
﹤0.01% 941
2021
Q2
$2K Hold
29
﹤0.01% 896
2021
Q1
$2K Hold
29
﹤0.01% 988
2020
Q4
$2K Hold
29
﹤0.01% 703
2020
Q3
$1K Hold
29
﹤0.01% 749
2020
Q2
$1K Hold
29
﹤0.01% 696
2020
Q1
$1K Hold
29
﹤0.01% 675
2019
Q4
$2K Hold
29
﹤0.01% 682
2019
Q3
$1K Hold
29
﹤0.01% 684
2019
Q2
$2K Hold
29
﹤0.01% 646
2019
Q1
$1K Buy
+29
New +$1.28K ﹤0.01% 641

Other funds holding XRAY

Capital Analysts LLC's XRAY Position: Q2 2026 in Review

Capital Analysts LLC sold out of Dentsply Sirona (XRAY) in Q2 2026, closing a stake of 130 shares — an estimated $2K sold.

Capital Analysts LLC first reported a position in XRAY in Q1 2019 and held it in 15 quarters. The position peaked at $2K in Q1 2026. 374 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

  • Capital Analysts LLC reported no remaining Dentsply Sirona position as of Q2 2026 after selling out during the quarter.
  • Capital Analysts LLC sold 130 Dentsply Sirona shares in Q2 2026, an estimated $2K.
  • Capital Analysts LLC first reported a position in Dentsply Sirona in Q1 2019 and held it in 15 quarters.
  • Capital Analysts LLC's Dentsply Sirona position peaked at $2K in Q1 2026.
  • 374 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.